{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:35:26Z","timestamp":1790116526181,"version":"4.0.1"},"reference-count":25,"publisher":"Baskent University","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.6002\/ect.2021.0432","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T04:45:08Z","timestamp":1653626708000},"page":"480-486","source":"Crossref","is-referenced-by-count":2,"title":["Anti-T-Lymphocyte Immunoglobulin (Grafalon) as an Induction Agent for Renal Transplantation: A Real-World, Retrospective, Single-Center Experience"],"prefix":"10.6002","volume":"20","author":[{"given":"Ashwani","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinant","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovy","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. S.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Cochrane Database Syst Rev. 2017;1(1):CD004759. doi:10.1002\/14651858.CD004759.pub2","DOI":"10.1002\/14651858.CD004759.pub2"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9 Suppl 3:S1-S155. doi:10.1111\/j.1600-6143.2009.02834.x","DOI":"10.1111\/j.1600-6143.2009.02834.x"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Padiyar A, Augustine JJ, Hricik DE. Induction antibody therapy in kidney transplantation. Am J Kidney Dis. 2009;54(5):935-944. doi:10.1053\/j.ajkd.2009.06.020","DOI":"10.1053\/j.ajkd.2009.06.020"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Popow I, Leitner J, Grabmeier-Pfistershammer K, et al. A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations. Am J Transplant. 2013;13(12):3103-3113. doi:10.1111\/ajt.12514","DOI":"10.1111\/ajt.12514"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Bamoulid J, Crepin T, Gaiffe E, et al. Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins. Transpl Immunol. 2017;45:48-52. doi:10.1016\/j.trim.2017.09.002","DOI":"10.1016\/j.trim.2017.09.002"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Feng X, Kajigaya S, Solomou EE, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood. 2008;111(7):3675-3683. doi:10.1182\/blood-2008-01-130146","DOI":"10.1182\/blood-2008-01-130146"},{"key":"ref6","unstructured":"7. THOA Amendment 2011. Accessed April 2, 2022. https:\/\/notto.gov.in\/act-end-rules-of-thoa.htm"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006;355(19):1967-1977. doi:10.1056\/NEJMoa060068","DOI":"10.1056\/NEJMoa060068"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Brennan DC, Schnitzler MA. Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med. 2008;359(16):1736-1738. doi:10.1056\/NEJMc0805714","DOI":"10.1056\/NEJMc0805714"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Yilmaz M, Sezer TO, Kir O, Ozturk A, Hoscoskun C, Toz H. Use of ATG-Fresenius as an induction agent in deceased-donor renal transplantation. Transplant Proc. 2017;49(3):486-489. doi:10.1016\/j.transproceed.2017.02.006","DOI":"10.1016\/j.transproceed.2017.02.006"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Chen GD, Lai XQ, Ko DS, et al. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study. Nephrology (Carlton). 2015;20(8):539-543. doi:10.1111\/nep.12469","DOI":"10.1111\/nep.12469"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Chai YX, Ji JL, Li SJ, et al. Efficacy of anti-T-lymphocyte globulin-Fresenius as an induction agent in deceased-donor renal transplantation: a cohort study. Exp Ther Med. 2020;19(3):2384-2390. doi:10.3892\/etm.2020.8451","DOI":"10.3892\/etm.2020.8451"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Engineer D, Patel H, Kute V, Shah P. Initial experience with ATG-F as induction agent in renal transplantation. J Clin Diagn Res. 2018;12(4):OC19-OC23.","DOI":"10.7860\/JCDR\/2018\/34005.11451"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Bacigalupo A. Antithymocyte globulin in the conditioning regimen: why not? Biol Blood Marrow Transplant. 2014;20(5):597-598. doi:10.1016\/j.bbmt.2014.03.011","DOI":"10.1016\/j.bbmt.2014.03.011"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Finke J, Bethge WA, Schmoor C, et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol. 2009;10(9):855-864. doi:10.1016\/S1470-2045(09)70225-6","DOI":"10.1016\/S1470-2045(09)70225-6"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Bacigalupo A, Lamparelli T, Bruzzi P, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood. 2001;98(10):2942-2947. doi:10.1182\/blood.v98.10.2942","DOI":"10.1182\/blood.V98.10.2942"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Ducloux D, Kazory A, Challier B, et al. Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study. Transplantation. 2004;77(7):1029-1033. doi:10.1097\/01.tp.0000116442.81259.60","DOI":"10.1097\/01.TP.0000116442.81259.60"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Abou-Jaoude MM, Almawi WY. Intraoperative anti-thymocyte globulin-Fresenius (ATG-F) administration as induction immunosuppressive therapy in kidney transplantation. Mol Immunol. 2003;39(17-18):1089-1094. doi:10.1016\/s0161-5890(03)00071-3","DOI":"10.1016\/S0161-5890(03)00071-3"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. van den Hoogen MW, Kho MM, Abrahams AC, et al. Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: a randomized study. Exp Clin Transplant. 2013;11(2):134-141. doi:10.6002\/ect.2012.0220","DOI":"10.6002\/ect.2012.0220"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Yang SL, Wang D, Wu WZ, et al. Comparison of single bolus ATG and basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen. Transpl Immunol. 2008;18(3):281-285. doi:10.1016\/j.trim.2007.08.002","DOI":"10.1016\/j.trim.2007.08.002"},{"key":"ref20","unstructured":"21. Samsel R, Pliszczy\u0144ski J, Chmura A, et al. Safety and efficacy of high dose ATG bolus administration on revascularization in kidney graft patients--long term results. Ann Transplant. 2008;13(1):32-39."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Kaden J, V\u00f6lp A, Wesslau C. High graft protection and low incidences of infections, malignancies and other adverse effects with intra-operative high dose ATG-induction: a single centre cohort study of 760 cases. Ann Transplant. 2013;18:9-22. doi:10.12659\/AOT.883792","DOI":"10.12659\/AOT.883792"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Meier-Kriesche HU, Arndorfer JA, Kaplan B. Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol. 2002;13(3):769-772. doi:10.1681\/ASN.V133769","DOI":"10.1681\/ASN.V133769"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Jha PK, Rana A, Kher A, et al. Grafalon\u00ae vs. Thymoglobulin\u00ae as an Induction Agent in Renal Transplantation - A Retrospective Study. Indian J Nephrol. 2021;31(4):336-340. doi:10.4103\/ijn.IJN_205_20","DOI":"10.4103\/ijn.IJN_205_20"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Gaber AO, Matas AJ, Henry ML, et al. Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry. Transplantation. 2012;94(4):331-337. doi:10.1097\/TP.0b013e31825a7d1f","DOI":"10.1097\/TP.0b013e31825a7d1f"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T06:15:08Z","timestamp":1653632108000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2022\/20\/5\/0\/480\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0432","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}